2 ms·
That is true but every pharma has a structural biology department that solves product-related crystal structures with the intent of using that data to speed dev
by dekhn 6y ago
That is true but every pharma has a structural biology department that solves product-related crystal structures with the intent of using that data to speed development. It's an established thing, $100+M/year budget per company.
Generally well-respected and considered some of the most important IP the company can generate.
They also have theory groups which try to do structure prediction and drug docking but I don't think those groups get any respect inside the companies any more.